Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines

por Talbot, D C, Moiseyenko, V, Van Belle, S, O'Reilly, S M, Alba Conejo, E, Ackland, S, Eisenberg, P, Melnychuk, D, Pienkowski, T, Burger, H-U, Laws, S, Osterwalder, B
Publicado 2002